ESCI期刊Clinical and Experimental Hepatology 2024/2025影响因子:1.523 (CLIN EXP HEPATOL) (2392-1099). (GASTROENTEROLOGY & HEPA

显示全部楼层 · 发表于 2025-3-25 18:25:07

Submitted on: 11 December 2000. Revised on: 13 March 2001. Accepted on: 23 April 2001. ___________________Clinical and Experimental Hepatology

显示全部楼层 · 发表于 2025-3-25 22:30:26

Submitted on: 12 June 2009. Revised on: 26 September 2009. Accepted on: 15 November 2009. ___________________Clinical and Experimental Hepatology

显示全部楼层 · 发表于 2025-3-26 01:53:38

显示全部楼层 · 发表于 2025-3-26 04:35:55

显示全部楼层 · 发表于 2025-3-26 08:51:09

Submitted on: 12 September 1999. Revised on: 02 January 2000. Accepted on: 19 February 2000. ___________________Clinical and Experimental Hepatology

显示全部楼层 · 发表于 2025-3-26 16:22:27

Submitted on: 07 July 2012. Revised on: 02 September 2012. Accepted on: 10 October 2012. ___________________Clinical and Experimental Hepatology

显示全部楼层 · 发表于 2025-3-26 17:51:36

Submitted on: 11 April 2016. Revised on: 12 July 2016. Accepted on: 05 September 2016. ___________________Clinical and Experimental Hepatology

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 03:08
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved